Hypersensitivity reaction is the over reactive immunological response towards antigens. In some cases, body’s own cells are miss-read as foreign cells and immune response is mounted against these cells. Hypersensitivity may lead to serious injuries, lifelong disorders and even death. There are two types of hypersensitivity reactions, namely, immediate hypersensitivity reaction and delayed hypersensitivity. Immediate reaction also called as allergic reactions involve antibodies while delayed type reactions involve T lymphocytes. Hypersensitivity reactions can be classified in to four main types (Gell and Coomb’s classification), follows:
  • Type I- immediate hypersensitivity reaction involving IgE 
  • Type II- cytotoxic hypersensitivity reaction involving IgG and IgM
  • Type III- immune-complex reaction involving circulation Ag-Ab (antigen-antibody) complex
  • Type IV- delayed hypersensitivity reactions involving T cells.   
Hypersensitivity may lead to various disorders such as asthma, erythroblastosis fetalis, goodpasture\'s syndrome, Graves\' disease, myasthenia gravis, rheumatoid arthritis, and systemic lupus erythematosus among others. Diagnosis of allergies is done using various molecular and immunoassays, which deliver quick and accurate test results. ImmunoCAP test by Thermo Fisher Scientific is one the most widely used test for allergy testing. 
Advent of multiplex technology has also revolution allergy testing, in which single sample can be tested for multiple analytes. The test is cost effective and also required very small amount of sample to conduct the test.       
 
Drug hypersensitivity is becoming a major concern, in which individuals suffer from allergy towards drugs, most common being insulin and beta lactums such as penicillin. Allergy is also a common disorder across the globe. According to World Allergy Organization, allergic rhinitis affects 10% to 30% of the global population while over 200 million individuals across the globe suffer from food allergy. The data further details that, more than 10% of the adverse drug reactions are unpredictable drug hypersensitivity reactions. The prevalence of lupus is higher in Europe and Australia as compared to North America. In North America, the disease is more prevalent among Hispanics, Asians, and Native Americans according to Centers for Disease Control and Prevention (CDC). Due to this high prevalence across the globe, the demand for quick and effective treatment and diagnosis of hypersensitivity reactions is increasing.     
 
As the clinical research advances, various drugs will be launched in the market offering better treatment for hypersensitivity. This will also add more products to the market and hence ensure continuous growth. Moreover as the drugs approach patent expiry, generic drugs are expected to hit the market, making treatment affordable to the developing and under developed countries; thus expanding geographical scope. The market is flooded with generic drugs for treatment of hypersensitivity reaction. Common drugs include astemizole, celiprolol, chlorpheniramine, diphenhydramine, fexofenadine, triamcinolone and various others. India being the home for generic drug manufacturers, the market is expected to boost as branded drugs lose their patents.  
 
GSK manufactured Benlysta (belimumab) is a B lymphocyte stimulator, received FDA approval in 2011 for treatment of lupus. Ibuprofen and aspirin are widely prescribed anti-inflammatory drugs for suppressing symptoms of lupus. Immunosuppressant such as CellCept (Mycophenolate mofetil) by Roche, Neoral (Cyclosporine) by Novartis, Imuran (Azathioprine) by GSK are commonly prescribed for lupus treatment. KALBITOR (ecallantide) by Dyax Corp is prescribed for acute hereditary angioedema (HAE). Other key players in the market include Cadila Pharmaceuticals Ltd., Admac Pharma Ltd., DWD Pharmaceuticals Ltd, Panacea Biotec Ltd, Dr Reddy Laboratories Ltd, Glenmark Pharmaceuticals Ltd., Cipla Limited, Glaxo Smith Kline Pharmaceuticals, Sun Pharmaceutical Industries Ltd.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hypersensitivity Market

Pre Book